Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FluidForm
AddedFeb 19, 2024
UpdatedJun 18, 2026
FluidForm

FluidForm

FluidForm, a leading provider of 3D bioprinting technology, specializes in additive manufacturing.

HQ
Waltham, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

FluidForm, founded with the mission to revolutionize medicine, specializes in 3D bioprinting technology. The company focuses on additive manufacturing to create living human tissues, aiming to transform disease treatment through its patented FRESH™ technology. This innovative platform enables the bioprinting of silicone and living tissues that incorporate cells and vasculature, targeting advanced cell therapy and chronic disease cures.

Notable figures affiliated with FluidForm include leading experts in bioengineering and regenerative medicine. The company has attracted significant interest from investors in the biotech sector. Key achievements include the successful development and application of their FRESH™ technology, positioning FluidForm as a pioneer in the bioprinting industry. Their impact is evident in the potential to revolutionize treatments for chronic diseases, offering new hope for advanced medical therapies.

FluidForm - Similar Companies

3DBio logo

3DBio

3dbiocorp.com

Precise Bio logo

Precise Bio

precise-bio.com

Formlabs logo

Formlabs

formlabs.com

BioFluidica logo

BioFluidica

biofluidica.com

Systemic Bio logo

Systemic Bio

systemic.bio

TissueForm logo

TissueForm

tissueforminc.com

VivoSim Labs logo

VivoSim Labs

organovo.com

Phase logo

Phase

phase.am

A.D.A.M. logo

A.D.A.M.

restor3d logo

restor3d

restor3d.com

Freeform logo

Freeform

freeform.co

Parallel Fluidics logo

Parallel Fluidics

ChemoSen3D logo

ChemoSen3D

chemosen3d.com

Flow Circuits logo

Flow Circuits

flowcircuits.com

Formi 3DP logo

Formi 3DP

FluidForm - Quick Facts

Who are FluidForm's competitors?

Companies similar to FluidForm include 3DBio, Precise Bio, Formlabs and BioFluidica.

When was FluidForm founded?

FluidForm was founded in 2018.

Where is FluidForm's headquarters located?

FluidForm's headquarters is located in Waltham, MA, US.

How much has FluidForm raised to-date?

As of Jan 11, 2022, FluidForm has raised a total of $499.6k (USD).

How many employees does FluidForm have?

FluidForm has 26 employees as of Feb 4, 2024.

FluidForm - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • 3D Printing
  • Bioprinting
Tags
  • Biotech
  • Platform
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries